VIRACTA THERAPEUTICS INC (VIRX) Stock Income Statement
USA - NASDAQ:VIRX - US92765F1084 - Common Stock
0.0778 USD
-0.07 (-48.65%)
0.071 USD
-0.01 (-8.74%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 120.00K | |||
| Operating Expenses | 47.21M | 50.69M | 50.59M | 25.80M | 22.42M | |||
| Research and Development | 33.09M | 33.37M | 26.26M | 23.86M | 12.26M | |||
| Selling, General, and Administrative Expenses | 14.12M | 17.32M | 24.33M | 15.44M | 10.16M | |||
| Operating Income | -47.21M | -50.69M | -50.59M | -25.80M | -22.30M | |||
| Interest Income/Expense | -1.07M | -359.00K | 590.00K | -450.00K | -300.00K | |||
| Other Income/Expense | 4.99M | -6.00K | 800.00K | -290.00K | 1.00M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -88.22M | N/A | |||
| Income Before Taxes | -43.29M | -51.06M | -49.20M | -114.76M | -21.61M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -43.29M | -51.06M | -49.20M | -114.76M | -21.61M | |||
| EBITDA | -46.77M | -50.20M | -50.38M | -25.62M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.10 | -1.32 | -1.30 | -3.60 | -5.37 | |||
| Non GAAP EPS | -1.10 | -1.32 | -1.30 | -0.61 | -5.60 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -18008.33% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -18583.33% | |||
All data in USD